ZA200705151B - G-protein coupled receptor (GPR116) and agonists use thereof for treating obesity and diabetes - Google Patents
G-protein coupled receptor (GPR116) and agonists use thereof for treating obesity and diabetesInfo
- Publication number
- ZA200705151B ZA200705151B ZA200705151A ZA200705151A ZA200705151B ZA 200705151 B ZA200705151 B ZA 200705151B ZA 200705151 A ZA200705151 A ZA 200705151A ZA 200705151 A ZA200705151 A ZA 200705151A ZA 200705151 B ZA200705151 B ZA 200705151B
- Authority
- ZA
- South Africa
- Prior art keywords
- gpr116
- diabetes
- coupled receptor
- protein coupled
- treating obesity
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/32—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0428212A GB0428212D0 (en) | 2004-12-24 | 2004-12-24 | Compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200705151B true ZA200705151B (en) | 2008-10-29 |
Family
ID=34113150
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200705151A ZA200705151B (en) | 2004-12-24 | 2007-06-21 | G-protein coupled receptor (GPR116) and agonists use thereof for treating obesity and diabetes |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN101123964B (en) |
GB (1) | GB0428212D0 (en) |
ZA (1) | ZA200705151B (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104761540A (en) * | 2015-03-12 | 2015-07-08 | 佛山市赛维斯医药科技有限公司 | Compound containing structures of nicotinamide and piperidine and application thereof |
CN104725309A (en) * | 2015-03-12 | 2015-06-24 | 佛山市赛维斯医药科技有限公司 | PTP1B inhibitor containing nicotinic acid amide structure and use thereof |
CN104725354A (en) * | 2015-03-12 | 2015-06-24 | 佛山市赛维斯医药科技有限公司 | Compound containing nicotinic acid amide and piperidine structures and use thereof |
CN104725353A (en) * | 2015-03-12 | 2015-06-24 | 佛山市赛维斯医药科技有限公司 | PTP1B inhibitor containing nicotinic acid amide and piperidine structures and use thereof |
CN104788424A (en) * | 2015-03-12 | 2015-07-22 | 佛山市赛维斯医药科技有限公司 | PTP1B inhibitors containing nicotinamide and piperidine structure, and preparation method and use thereof |
CN104725308A (en) * | 2015-03-12 | 2015-06-24 | 佛山市赛维斯医药科技有限公司 | PTP1B inhibitor containing nicotinic acid amide structure and preparation method and use thereof |
CN104788425A (en) * | 2015-03-12 | 2015-07-22 | 佛山市赛维斯医药科技有限公司 | PTP1B inhibitors containing nicotinamide and piperidine structure, and preparation method and use thereof |
CN106831559A (en) * | 2015-03-12 | 2017-06-13 | 佛山市赛维斯医药科技有限公司 | A kind of PTP1B inhibitor, preparation method and its usage containing niacin hydroxyacyl amine structure |
CN106748999A (en) * | 2015-03-12 | 2017-05-31 | 佛山市赛维斯医药科技有限公司 | PTP1B inhibitor, preparation method and its usage of one class containing niacin hydroxyacyl amine structure |
CN104725311A (en) * | 2015-03-12 | 2015-06-24 | 佛山市赛维斯医药科技有限公司 | PTP1B inhibitor containing nicotinic acid amide structure and use thereof |
CN106831561A (en) * | 2015-03-12 | 2017-06-13 | 佛山市赛维斯医药科技有限公司 | A kind of PTP1B inhibitor containing niacin hydroxyacyl amine and aniline structure, its preparation and purposes |
CN104725355A (en) * | 2015-03-12 | 2015-06-24 | 佛山市赛维斯医药科技有限公司 | PTP1B inhibitor containing nicotinic acid amide and piperidine structures and use thereof |
CN104725310A (en) * | 2015-03-12 | 2015-06-24 | 佛山市赛维斯医药科技有限公司 | PTP1B inhibitor containing nicotinic acid amide and aniline structures and use thereof |
CN114404597A (en) * | 2022-01-10 | 2022-04-29 | 中国人民解放军海军军医大学第一附属医院 | Medicine and pharmaceutical composition for treating lung injury or acute respiratory distress syndrome |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GEP20084540B (en) * | 2003-01-14 | 2008-11-25 | Arena Pharm Inc | 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prpphylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
WO2005061489A1 (en) * | 2003-12-24 | 2005-07-07 | Prosidion Limited | Heterocyclic derivatives as gpcr receptor agonists |
-
2004
- 2004-12-24 GB GB0428212A patent/GB0428212D0/en not_active Ceased
-
2005
- 2005-12-23 CN CN200580048550XA patent/CN101123964B/en not_active Expired - Fee Related
-
2007
- 2007-06-21 ZA ZA200705151A patent/ZA200705151B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN101123964A (en) | 2008-02-13 |
GB0428212D0 (en) | 2005-01-26 |
CN101123964B (en) | 2012-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200705151B (en) | G-protein coupled receptor (GPR116) and agonists use thereof for treating obesity and diabetes | |
IL205381A0 (en) | Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes | |
PL1817072T3 (en) | Apparatus for reducing obesity | |
HRP20180667T1 (en) | A klotho-beta agonist antibody for use in the treatment of diabetes mellitus or insulin resistance | |
GB0607196D0 (en) | G-protein coupled receptor agonists | |
IL252700A0 (en) | Process for preparing an a2a-adenosine receptor agonist and its polymorphs | |
EP2182807A4 (en) | Cannabinoid receptor antagonists/inverse agonists useful for treating obesity | |
ZA200807789B (en) | Neuromedin U receptor agonists and uses thereof | |
HK1132218A1 (en) | Device and process for binding assays | |
TWI350406B (en) | Liquid crystal device, light-emitting device, and electronic apparatus | |
EP1766158A4 (en) | Arm apparatus with reinforcement | |
GB2455921B (en) | Sampling apparatus for use in boreholes | |
EP1777572A4 (en) | Observation apparatus having thermoregulation mechanism | |
EP1782832A4 (en) | Remedy for diabetes | |
EP1723178A4 (en) | Human g-protein chemokine receptor (ccr5) hdgnr10 | |
IL188668A0 (en) | Daily dosage regimen for treating diabetes, obesity, metabolic syndrome and polycystic ovary syndrome | |
GB2428390B (en) | Agitation device for sample containers | |
EP1984724A4 (en) | Device and methods for quantifying analytes | |
TWI340951B (en) | Light-emitting device, image forming apparatus, and electronic apparatus | |
EP1699230A4 (en) | Turning hinge mechanism and image pick up device | |
ZA200806666B (en) | Process for preparing an A2A-adenosine receptor agonist and its polymorphs | |
DE602007004884D1 (en) | Caching mechanism and printer | |
ZA200810681B (en) | Treating obesity with muscaring receptor mi antagonists | |
EP1958781A4 (en) | Printing apparatus and its cleaning mechanism | |
IL179546A0 (en) | Uses of gpr100 receptor in diabetes and obesity regulation |